RSV Updated Cepheid SARS-CoV-2, Flu, RSV Test Nabs FDA EUA The new version of the multiplex test adds a third gene target for SARS-CoV-2 to detect future viral mutations. Test for Them All The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza. Nature Papers on Single-Cell RNA-Seq Data Preprocessing, Defective Viral Genomes In Nature this week: new single-cell RNA sequencing data preprocessing approach, and more. PNAS Papers on South American Population History, Venom Network, More In PNAS this week: Australasian-related ancestry among South Americans, gene expression in venom production, and more. Amazon, NeuMoDx, Becton Dickinson Get FDA Emergency Use Authorizations for Coronavirus Tests Amazon said that it will use its test for employees and other individuals who enter its facilities as part of its COVID-19 preparedness and response program. Jan 25, 2021 Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets Premium Jan 19, 2021 Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M Dec 18, 2020 Bruker Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Panel Dec 15, 2020 GeneFirst Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test Kit Dec 15, 2020 EliTech SARS-CoV-2, Influenza, RSV Multiplex Test Receives CE Mark Dec 7, 2020 Thermo Fisher Scientific Gets CE Mark for COVID-19, Flu A/B, RSV Kit Nov 24, 2020 Cepheid Receives CE Mark for SARS-CoV-2, Flu A/B, RSV Combination Test Nov 16, 2020 Qiagen Obtains CE Mark for Multiplex Respiratory Infection Test, Saliva-Based SARS-CoV-2 Assay Oct 21, 2020 BD, CerTest Biotec Get CE-IVD Mark for Combination COVID-19, Influenza, RSV Test on BD Max Oct 13, 2020 FDA Relaxes Rules for Flu, RSV Molecular Tests During Coronavirus Health Emergency Sep 30, 2020 BioGX BV Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test Sep 25, 2020 Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization Sep 25, 2020 Abacus Diagnostica Readying Multiplex RT-PCR Test for SARS-CoV-2, Flu, RSV Premium Sep 17, 2020 Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M Sep 14, 2020 GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu Sep 8, 2020 Scope Fluidics Secures €10M Loan From European Investment Bank Sep 8, 2020 FDA Clears DiaSorin Test for Influenza, RSV Aug 27, 2020 Novacyt Gets CE Mark for Coronavirus, Flu, RSV Combo Panel Jul 7, 2020 DiaSorin Molecular Gets CE Mark for Flu, RSV Assay Apr 22, 2020 Researchers See Immune, Age Contributors to Childhood Respiratory Virus Response Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.